Dr. Alok K. Kothari
Claim this profilePhoenix Childrens Hospital
Expert in Cancer
Studies Soft Tissue Sarcoma
17 reported clinical trials
41 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Soft Tissue Sarcoma
Stage IV
RB positive
Stage I
Affiliated Hospitals
Clinical Trials Alok K. Kothari is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Alok K. Kothari
Clinical Trial Related7 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Alok K. Kothari has experience with
- Cyclophosphamide
- Ramucirumab
- Irinotecan
- Vinorelbine
- Docetaxel
- Gemcitabine
Breakdown of trials Alok K. Kothari has run
Cancer
Soft Tissue Sarcoma
Rhabdomyosarcoma
Ewing's Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alok K. Kothari specialize in?
Alok K. Kothari focuses on Cancer and Soft Tissue Sarcoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Alok K. Kothari currently recruiting for clinical trials?
Yes, Alok K. Kothari is currently recruiting for 8 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Alok K. Kothari has studied deeply?
Yes, Alok K. Kothari has studied treatments such as Cyclophosphamide, Ramucirumab, Irinotecan.
What is the best way to schedule an appointment with Alok K. Kothari?
Apply for one of the trials that Alok K. Kothari is conducting.
What is the office address of Alok K. Kothari?
The office of Alok K. Kothari is located at: Phoenix Childrens Hospital, Phoenix, Arizona 85016 United States. This is the address for their practice at the Phoenix Childrens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.